Evaluation of the effectiveness of anti-infectives treatments

62f - Microarray-ADN

Service description

This technology uses in vivo imaging technologies to monitor the implementation of a bacterial infection, its evolution and its resolution by treatment (antibiotic or alternative approach). After modifying a pathogenic bacterium to make it bioluminescent, it is used in a preclinical model (urinary tract infection, pneumonia, septicaemia, skin infection, surgical site infection, biofilm...). This model is then adapted to the therapeutic solution to be evaluated (small molecule, antibiotic, host-oriented therapy, immunomodulator, phage, phytotherapy...). A biodistribution or pharmacokinetic study may precede the evaluation of the efficacy of the treatment. Finally, an optimization of the therapeutic regimen can complete the study, particularly in the case of combinations.

Materials to provide

  • Information regarding the required tests

    Further details on the project may be requested.

You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Study following the specifications validated with the Expert

Get started with your treatment evaluation

Please answer the fields below to be contacted by our team of scientists

section1-3
Back
home